Feasibility of simplifying renal dosimetry in (177)Lu peptide receptor radionuclide therapy

BACKGROUND: Recently, (177)Lu-dotatate therapy for neuroendocrine tumours has received regulatory approval. Dosimetry can be used to optimize treatment on an individual basis, but there is no international consensus as to how it should be done. The aim of this study is to determine a feasible and ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Sundlöv, Anna, Gustafsson, Johan, Brolin, Gustav, Mortensen, Nadja, Hermann, Rebecca, Bernhardt, Peter, Svensson, Johanna, Ljungberg, Michael, Tennvall, Jan, Sjögreen Gleisner, Katarina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031553/
https://www.ncbi.nlm.nih.gov/pubmed/29974391
http://dx.doi.org/10.1186/s40658-018-0210-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031553/
https://www.ncbi.nlm.nih.gov/pubmed/29974391
http://dx.doi.org/10.1186/s40658-018-0210-2

Ejemplares similares